178 related articles for article (PubMed ID: 26535075)
1. Lipid A as a Drug Target and Therapeutic Molecule.
Joo SH
Biomol Ther (Seoul); 2015 Nov; 23(6):510-6. PubMed ID: 26535075
[TBL] [Abstract][Full Text] [Related]
2. Rationally Designed TLR4 Ligands for Vaccine Adjuvant Discovery.
Gregg KA; Harberts E; Gardner FM; Pelletier MR; Cayatte C; Yu L; McCarthy MP; Marshall JD; Ernst RK
mBio; 2017 May; 8(3):. PubMed ID: 28487429
[TBL] [Abstract][Full Text] [Related]
3. Bacterial Lipoprotein Biosynthetic Pathway as a Potential Target for Structure-based Design of Antibacterial Agents.
Xia J; Feng B; Wen G; Xue W; Ma G; Zhang H; Wu S
Curr Med Chem; 2020; 27(7):1132-1150. PubMed ID: 30360704
[TBL] [Abstract][Full Text] [Related]
4. Therapeutic compounds targeting Lipid II for antibacterial purposes.
Malin JJ; de Leeuw E
Infect Drug Resist; 2019; 12():2613-2625. PubMed ID: 31692545
[TBL] [Abstract][Full Text] [Related]
5. Discovery of the Elusive UDP-Diacylglucosamine Hydrolase in the Lipid A Biosynthetic Pathway in Chlamydia trachomatis.
Young HE; Zhao J; Barker JR; Guan Z; Valdivia RH; Zhou P
mBio; 2016 Mar; 7(2):e00090. PubMed ID: 27006461
[TBL] [Abstract][Full Text] [Related]
6. Inhibitors targeting on cell wall biosynthesis pathway of MRSA.
Hao H; Cheng G; Dai M; Wu Q; Yuan Z
Mol Biosyst; 2012 Nov; 8(11):2828-38. PubMed ID: 22898792
[TBL] [Abstract][Full Text] [Related]
7. Targeting a cell wall biosynthesis hot spot.
Müller A; Klöckner A; Schneider T
Nat Prod Rep; 2017 Jul; 34(7):909-932. PubMed ID: 28675405
[TBL] [Abstract][Full Text] [Related]
8. Antibacterial Drug Discovery Targeting the Lipopolysaccharide Biosynthetic Enzyme LpxC.
Erwin AL
Cold Spring Harb Perspect Med; 2016 Jul; 6(7):. PubMed ID: 27235477
[TBL] [Abstract][Full Text] [Related]
9. Benzothiazole-based Compounds in Antibacterial Drug Discovery.
Gjorgjieva M; Tomašič T; Kikelj D; Mašič LP
Curr Med Chem; 2018; 25(38):5218-5236. PubMed ID: 28990510
[TBL] [Abstract][Full Text] [Related]
10. [The history of the development and changes of quinolone antibacterial agents].
Takahashi H; Hayakawa I; Akimoto T
Yakushigaku Zasshi; 2003; 38(2):161-79. PubMed ID: 15143768
[TBL] [Abstract][Full Text] [Related]
11. Interplay of Klebsiella pneumoniae
Mostafavi M; Wang L; Xie L; Takeoka KT; Richie DL; Casey F; Ruzin A; Sawyer WS; Rath CM; Wei JR; Dean CR
mSphere; 2018 Oct; 3(5):. PubMed ID: 30381354
[TBL] [Abstract][Full Text] [Related]
12. Three Principles of Diversity-Generating Biosynthesis.
Gu W; Schmidt EW
Acc Chem Res; 2017 Oct; 50(10):2569-2576. PubMed ID: 28891639
[TBL] [Abstract][Full Text] [Related]
13. Docking on Lipid II-A Widespread Mechanism for Potent Bactericidal Activities of Antibiotic Peptides.
Grein F; Schneider T; Sahl HG
J Mol Biol; 2019 Aug; 431(18):3520-3530. PubMed ID: 31100388
[TBL] [Abstract][Full Text] [Related]
14. New Found Hope for Antibiotic Discovery: Lipid II Inhibitors.
Ng V; Chan WC
Chemistry; 2016 Aug; 22(36):12606-16. PubMed ID: 27388768
[TBL] [Abstract][Full Text] [Related]
15. UDP-3-O-(R-3-hydroxymyristoyl)-N-acetylglucosamine deacetylase (LpxC) inhibitors: a new class of antibacterial agents.
Zhang J; Zhang L; Li X; Xu W
Curr Med Chem; 2012; 19(13):2038-50. PubMed ID: 22414079
[TBL] [Abstract][Full Text] [Related]
16. Editorial: Current status and perspective on drug targets in tubercle bacilli and drug design of antituberculous agents based on structure-activity relationship.
Tomioka H
Curr Pharm Des; 2014; 20(27):4305-6. PubMed ID: 24245755
[TBL] [Abstract][Full Text] [Related]
17. A Small-Molecule Screening Platform for the Discovery of Inhibitors of Undecaprenyl Diphosphate Synthase.
Czarny TL; Brown ED
ACS Infect Dis; 2016 Jul; 2(7):489-99. PubMed ID: 27626101
[TBL] [Abstract][Full Text] [Related]
18. Bacterial fatty acid metabolism in modern antibiotic discovery.
Yao J; Rock CO
Biochim Biophys Acta Mol Cell Biol Lipids; 2017 Nov; 1862(11):1300-1309. PubMed ID: 27668701
[TBL] [Abstract][Full Text] [Related]
19. Mur Ligase Inhibitors as Anti-bacterials: A Comprehensive Review.
Sangshetti JN; Joshi SS; Patil RH; Moloney MG; Shinde DB
Curr Pharm Des; 2017; 23(21):3164-3196. PubMed ID: 28201974
[TBL] [Abstract][Full Text] [Related]
20. Insights into Integrated Lead Generation and Target Identification in Malaria and Tuberculosis Drug Discovery.
Okombo J; Chibale K
Acc Chem Res; 2017 Jul; 50(7):1606-1616. PubMed ID: 28636311
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
